In the present study we demonstrate that dietary AXT inhibits tumour progression based on abrogation of the JAK/STAT3 pathway and its downstream targets cyclin D1, MMP-2, -9, and VEGF in the HBP carcinogenesis model. The gene discussed is VEGFA; the disease is neoplasm.